132 related articles for article (PubMed ID: 12969974)
1. Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease.
Takagi M; Tsuchida R; Oguchi K; Shigeta T; Nakada S; Shimizu K; Ohki M; Delia D; Chessa L; Taya Y; Nakanishi M; Tsunematsu Y; Bessho F; Isoyama K; Hayashi Y; Kudo K; Okamura J; Mizutani S
Blood; 2004 Jan; 103(1):283-90. PubMed ID: 12969974
[TBL] [Abstract][Full Text] [Related]
2. Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement.
Oguchi K; Takagi M; Tsuchida R; Taya Y; Ito E; Isoyama K; Ishii E; Zannini L; Delia D; Mizutani S
Blood; 2003 May; 101(9):3622-7. PubMed ID: 12511424
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
4. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
[TBL] [Abstract][Full Text] [Related]
6. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
[TBL] [Abstract][Full Text] [Related]
7. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.
Delia D; Piane M; Buscemi G; Savio C; Palmeri S; Lulli P; Carlessi L; Fontanella E; Chessa L
Hum Mol Genet; 2004 Sep; 13(18):2155-63. PubMed ID: 15269180
[TBL] [Abstract][Full Text] [Related]
8. ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes.
Delia D; Mizutani S; Panigone S; Tagliabue E; Fontanella E; Asada M; Yamada T; Taya Y; Prudente S; Saviozzi S; Frati L; Pierotti MA; Chessa L
Br J Cancer; 2000 Jun; 82(12):1938-45. PubMed ID: 10864201
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ATM gene mutations in 66 ataxia telangiectasia families.
Sandoval N; Platzer M; Rosenthal A; Dörk T; Bendix R; Skawran B; Stuhrmann M; Wegner RD; Sperling K; Banin S; Shiloh Y; Baumer A; Bernthaler U; Sennefelder H; Brohm M; Weber BH; Schindler D
Hum Mol Genet; 1999 Jan; 8(1):69-79. PubMed ID: 9887333
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation.
Chen K; Albano A; Ho A; Keaney JF
J Biol Chem; 2003 Oct; 278(41):39527-33. PubMed ID: 12890678
[TBL] [Abstract][Full Text] [Related]
11. Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.
Jacquemin V; Rieunier G; Jacob S; Bellanger D; d'Enghien CD; Laugé A; Stoppa-Lyonnet D; Stern MH
Eur J Hum Genet; 2012 Mar; 20(3):305-12. PubMed ID: 22071889
[TBL] [Abstract][Full Text] [Related]
12. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
Das KC; Dashnamoorthy R
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
[TBL] [Abstract][Full Text] [Related]
13. Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences.
Kodama M; Otsubo C; Hirota T; Yokota J; Enari M; Taya Y
Mol Cell Biol; 2010 Apr; 30(7):1620-33. PubMed ID: 20123963
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.
Bonnen PE; Story MD; Ashorn CL; Buchholz TA; Weil MM; Nelson DL
Am J Hum Genet; 2000 Dec; 67(6):1437-51. PubMed ID: 11078475
[TBL] [Abstract][Full Text] [Related]
15. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM
J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771
[TBL] [Abstract][Full Text] [Related]
16. Identification of an ataxia telangiectasia-mutated protein mediated surveillance system to regulate Bcl-2 overexpression.
Zhang J; Lahti JM; Bruce A; He L; Parihar K; Fan C; Grenet J; Liu L; Kidd VJ; Cormier S; Tang D
Oncogene; 2006 Sep; 25(41):5601-11. PubMed ID: 16636671
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity.
Menotta M; Biagiotti S; Bianchi M; Chessa L; Magnani M
J Biol Chem; 2012 Nov; 287(49):41352-63. PubMed ID: 23055520
[TBL] [Abstract][Full Text] [Related]
18. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
[TBL] [Abstract][Full Text] [Related]
19. ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation.
de Toledo SM; Azzam EI; Dahlberg WK; Gooding TB; Little JB
Oncogene; 2000 Dec; 19(54):6185-93. PubMed ID: 11175332
[TBL] [Abstract][Full Text] [Related]
20. Chromatin modifying protein 1A (Chmp1A) of the endosomal sorting complex required for transport (ESCRT)-III family activates ataxia telangiectasia mutated (ATM) for PanC-1 cell growth inhibition.
Manohar S; Harlow M; Nguyen H; Li J; Hankins GR; Park M
Cell Cycle; 2011 Aug; 10(15):2529-39. PubMed ID: 21705858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
